✦ LIBER ✦

The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature

✍ Scribed by Lepretre, Stéphane; Jäger, Uli; Janssens, Ann; Leblond, Veronique; Nikitin, Eugene; Robak, Tadeusz; Wendtner, Clemens-Martin

Book ID: 111922933
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 435 KB
Volume: 53
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2011.631636

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancing the action of rituximab by add

Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia

✍ Wei Xu; Kou-Rong Miao; Dan-Xia Zhu; Cheng Fang; Hua-Yuan Zhu; Hua-Jie Dong; Dong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 280 KB

## Abstract Complement deficiencies have been identified in many chronic lymphocytic leukemia (CLL) patients. Supplying fresh frozen plasma (FFP)‐derived complement can enhance complement‐dependent cell lysis by the rituximab. The objective of our study was to evaluate the clinical efficacy and saf

Rituximab in combination with high-dose

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

✍ Castro, J E; Sandoval-Sus, J D; Bole, J; Rassenti, L; Kipps, T J 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

Fludarabine plus cyclophosphamide for th

Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia

✍ Ettore Mariano Schiavone; Mariacarla De Simone; Salvatore Palmieri; Mario Annunz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Cost-effectiveness of adding rituximab t

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia

✍ Hornberger, John; Reyes, Carolina; Shewade, Ashwini; Lerner, Susan; Friedmann, M 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 369 KB

Fludarabine, cyclophosphamide, and ritux

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-hodgkin lymphoma

✍ Constantine S. Tam; Max Wolf; H. Miles Prince; E. Henry Januszewicz; David Weste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Rituximab in combination with high-dose

Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia

✍ Lukáš Smolej; Michael Doubek; Anna Panovská; Martin Šimkovič; Yvona Brychtová; D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 291 KB